Benitec Biopharma Inc (NASDAQ: BNTC) flaunted slowness of -23.95% at $12.0, as the Stock market unbolted on thursday, before settling in for the price of $15.78 at the close. Taking a more long-term approach, BNTC posted a 52-week range of $9.10-$17.15.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 62.31%. Meanwhile, its Annual Earning per share during the time was 62.31%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -118.10%. This publicly-traded company’s shares outstanding now amounts to $26.25 million, simultaneously with a float of $25.21 million. The organization now has a market capitalization sitting at $315.00 million. At the time of writing, stock’s 50-day Moving Average stood at $14.51, while the 200-day Moving Average is $13.38.
Benitec Biopharma Inc (BNTC) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Benitec Biopharma Inc industry. Benitec Biopharma Inc’s current insider ownership accounts for 3.95%, in contrast to 90.69% institutional ownership. According to the most recent insider trade that took place on Mar 31 ’25, this organization’s Director bought 16,497 shares at the rate of 12.83, making the entire transaction reach 211,736 in total value, affecting insider ownership by 8,807,805. Preceding that transaction, on Mar 26 ’25, Company’s Director bought 900,000 for 13.00, making the whole transaction’s value amount to 11,700,000. This particular insider is now the holder of 8,793,245 in total.
Benitec Biopharma Inc (BNTC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year. Benitec Biopharma Inc’s EPS decrease for this current 12-month fiscal period is -118.10% and is forecasted to reach -2.86 in the upcoming year.
Benitec Biopharma Inc (NASDAQ: BNTC) Trading Performance Indicators
Let’s observe the current performance indicators for Benitec Biopharma Inc (BNTC). It’s Quick Ratio in the last reported quarter now stands at 54.67.
In the same vein, BNTC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.26, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -2.86 at the market close of one year from today.
Technical Analysis of Benitec Biopharma Inc (BNTC)
Now, what If we examine the latest scores posted by [Benitec Biopharma Inc, BNTC]. During the last 5-days, its volume was better the volume of 78479.0 it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 51.20% While, its Average True Range was 18.56.
Raw Stochastic average of Benitec Biopharma Inc (BNTC) in the period of the previous 100 days is set at 23.66%, which indicates a major rise in contrast to 8.90% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.22 that was higher than 0.83 volatility it exhibited in the past 100-days period.
